In last trading session, Achieve Life Sciences Inc (NASDAQ:ACHV) saw 0.56 million shares changing hands with its beta currently measuring 1.51. Company’s recent per share price level of $3.08 trading at $0.35 or 12.82% at ring of the bell on the day assigns it a market valuation of $106.83M. That closing price of ACHV’s stock is at a discount of -81.49% from its 52-week high price of $5.59 and is indicating a premium of 40.26% from its 52-week low price of $1.84. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 179.96K if we extend that period to 3-months.
For Achieve Life Sciences Inc (ACHV), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Achieve Life Sciences Inc (NASDAQ:ACHV) trade information
Upright in the green during last session for gaining 12.82%, in the last five days ACHV remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $3.08 price level, adding 0.65% to its value on the day. Achieve Life Sciences Inc’s shares saw a change of -12.50% in year-to-date performance and have moved 31.06% in past 5-day. Achieve Life Sciences Inc (NASDAQ:ACHV) showed a performance of 45.97% in past 30-days. Number of shares sold short was 2.53 million shares which calculate 11.57 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 4.75 to the stock, which implies a rise of 35.16% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 5.5. It follows that stock’s current price would drop -29.87% in reaching the projected high whereas dropping to the targeted low would mean a loss of -29.87% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 50.01% during past 5 years.
Achieve Life Sciences Inc (NASDAQ:ACHV)’s Major holders
Insiders are in possession of 9.69% of company’s total shares while institution are holding 41.57 percent of that, with stock having share float percentage of 46.03%. Investors also watch the number of corporate investors in a company very closely, which is 41.57% institutions for Achieve Life Sciences Inc that are currently holding shares of the company. FRANKLIN RESOURCES INC is the top institutional holder at ACHV for having 6.05 million shares of worth $19.6 million. And as of 2024-06-30, it was holding 17.6358 of the company’s outstanding shares.
The second largest institutional holder is PROPEL BIO MANAGEMENT, LLC, which was holding about 2.45 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.148 of outstanding shares, having a total worth of $11.53 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.03 shares of worth $3.17 million or 2.96% of the total outstanding shares. The later fund manager was in possession of 933.35 shares on Jan 31, 2025 , making its stake of worth around $2.87 million in the company or a holder of 2.69% of company’s stock.
